What is it about?

This study assesses the utility of the 6-minute walk test as as a method of quantitating exercise tolerance in dogs with neuromuscular disease, for use in both clinical and research settings.

Featured Image

Why is it important?

Validation of the 6MWT for use in dogs with neuromuscular disease could prove similarly useful in clinical and research settings. For research, quantitation of neuromuscular function is essential in therapeutic trials involving canine models of human neuromuscular disease, as a measure of response to treatment. In the clinical setting, the 6MWT could serve as an objective measure of the degree of clinical improvement of dogs with neuromuscular disease.

Read the Original

This page is a summary of: Noninvasive Assessment of Neuromuscular Disease in Dogs: Use of the 6‐minute Walk Test to Assess Submaximal Exercise Tolerance in Dogs with Centronuclear Myopathy, Journal of Veterinary Internal Medicine, March 2016, Wiley,
DOI: 10.1111/jvim.13939.
You can read the full text:

Read

Contributors

The following have contributed to this page